First Manhattan CO Xoma Corp Transaction History

First Manhattan CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$13.82 - $19.13 $34,550 - $47,825	-2,500 Reduced 33.33%	5,000 $92,000
Q3 2022 Nov 14, 2022	SELL	$15.9 - $29.56 $39,750 - $73,900	-2,500 Reduced 25.0%	7,500 $134,000
Q1 2022 May 16, 2022	BUY	$19.62 - $29.61 $49,050 - $74,025	2,500 Added 33.33%	10,000 $279,000
Q4 2021 Feb 14, 2022	SELL	$20.04 - $27.57 $50,100 - $68,925	-2,500 Reduced 25.0%	7,500 $156,000
Q3 2020 Nov 12, 2020	SELL	$16.25 - $20.94 $46,621 - $60,076	-2,869 Reduced 22.29%	10,000 $188,000
Q2 2020 Aug 14, 2020	SELL	$18.45 - $25.51 $7,029 - $9,719	-381 Reduced 2.88%	12,869 $254,000
Q1 2020 May 06, 2020	SELL	$15.11 - $28.71 $26,442 - $50,242	-1,750 Reduced 11.67%	13,250 $269,000
Q3 2019 Nov 13, 2019	SELL	$15.02 - $21.51 $75,100 - $107,550	-5,000 Reduced 25.0%	15,000 $295,000
Q1 2019 Apr 12, 2019	BUY	$11.95 - $15.53 $119,500 - $155,300	10,000 Added 100.0%	20,000 $247,000
Q3 2017 Oct 25, 2017	BUY	$7.31 - $20.8 $73,100 - $208,000	10,000	10,000 $196,000

6.5M

100

1.6K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $371M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.